000 01246 a2200301 4500
005 20250514162708.0
264 0 _c20040720
008 200407s 0 0 eng d
022 _a0956-5507
024 7 _a10.1046/j.0956-5507.2003.00105.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJärvinen, T A H
245 0 0 _aTopoisomerase IIalpha gene (TOP2A) amplification and deletion in cancer--more common than anticipated.
_h[electronic resource]
260 _bCytopathology : official journal of the British Society for Clinical Cytology
_cDec 2003
300 _a309-13 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review; Comment
650 0 4 _aAntigens, Neoplasm
650 0 4 _aBreast Neoplasms
_xgenetics
650 0 4 _aDNA Topoisomerases, Type II
_xgenetics
650 0 4 _aDNA-Binding Proteins
650 0 4 _aGene Amplification
650 0 4 _aGene Deletion
650 0 4 _aHumans
650 0 4 _aPoly-ADP-Ribose Binding Proteins
700 1 _aLiu, E T
773 0 _tCytopathology : official journal of the British Society for Clinical Cytology
_gvol. 14
_gno. 6
_gp. 309-13
856 4 0 _uhttps://doi.org/10.1046/j.0956-5507.2003.00105.x
_zAvailable from publisher's website
999 _c14368998
_d14368998